Glatiramer: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Glatiramer. Educational only — not medical advice.

Labeled uses

Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Source: FDA labeling via NIH DailyMed (set 7a573ffb…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.